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Abstract 
Different studies have pointed out Navarre as one of the regions of Spain with the highest inci-
dence rates of brain and other central nervous system (CNS) cancer. Trend analysis for cancer 
incidence rates for long periods of time, might help determining risk factors as well as, assessing 
prevention actions involved in this disease. The objective of this study was to describe the inci-
dence of brain and CNS cancer using data from the population-based cancer registry of Navarre, 
(Spain) during the period 1973-2008 and provide forecast figures up to-2014. Crude and 
age-standardized (world population) incidence rates of brain cancer per 100,000 person-years 
were calculated by the direct method separately by gender, area (Pamplona and others), and 
age-groups. Penalized splines for smoothing rates in the temporal dimensions were applied in 
order to estimate and forecast cancer incidence rates. Age-adjusted incidence rates showed an 
increase over the study and forecast periods in both sexes more marked in women than in men. 
Higher incidence rates were observed in men compared with women but the differences became 
smaller with time. The increase was due to the rise of rates in the oldest age groups since the rates 
for younger age groups remained stable or decreased over time. As the entire aetiology of brain 
and other CNS cancer is not still clear, keep promoting healthful lifestyles for cancer primary 
prevention among the whole population is necessary. 
Key words: Brain Cancer Incidence, Trend analysis, Projections, Population-based cancer registries, 
Spain 
Introduction 
According to the latest brain and other nervous 
system cancer figures published by GLOBOCAN, 
139,608 and 116,605 new cases were diagnosed in 2012 
worldwide in male and female, representing 3.9 and 
3.0 per 100,000 person-years [1]. Data from the Inter-
national Agency for Research on Cancer (IARC) pub-
lication, Cancer Incidence in Five Continents (CI5C), 
Vol. X (2003-2007), show high brain cancer incidence 
rates in Navarre, Spain: 7.8 and 5.7 per 100,000 in male 
and female respectively, which are among the first 
twelve highest rates registered for each gender [2]. 
Brain and nervous system cancer represents 2.3% of 
the total cancer incident cases registered in Navarre 
[2]. Navarre is one of the 17 Autonomous Regions of 
Spain located in the north of the country at the west-
ern end of the Pyrenees, bordering the Basque Coun-
try, La Rioja, and Aragon in Spain and Aquitaine in 
France.  
This region has historically shown high brain 
cancer incidence and mortality rates. A previous ge-
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ographical analysis of brain cancer mortality per-
formed in Spain showed a cluster of highest risk for 
Navarre and Basque Country regions. These results 
shown in the Atlas of Mortality for Cancer and other 
Causes in Spain (1978-1992) [3] revealed high risk of 
brain cancer mortality in Navarre, which registered 
the highest rates in Spain for both sexes, with a male 
mortality rate of 8.45 per 100,000 person-years versus 
a figure of 5.44 for Spain as a whole, and a female 
mortality rate of 4.69 versus a national figure of 3.30. 
These rates were adjusted using the European stand-
ard population [4]. Those figures motivated the per-
formance of another geographical study in Navarre 
and the Basque Country where the association of 
brain cancer incidence and the types of crop and 
phytosanitary treatments used in rural areas were 
analyzed [5]. In that study, the authors did not find 
association between brain cancer incidence pattern 
and the use of specific type of land cover and/or crop 
in those regions.  
Regarding the causes of brain and other central 
nervous system (CNS) tumours, it is generally ac-
cepted that brain cancer may be due to an alteration in 
the person’s inherited genetic factors or caused by 
environmental factors [6-9]. Some studies have found 
a positive association between brain cancer and the 
socioeconomic status [10-13]. In this sense, Navarre is 
ranked in the highest quintiles as regards per capita 
income among Spain’s regions [14]. The use of mobile 
phones has also been investigated as a risk factor [16]. 
These researchers followed up the mobile phone 
subscriber since 1982-95 until 2007 in Denmark, with a 
focus on tumours of the CNS. The authors did not 
find evidence of an increased risk of tumours of the 
CNS. Moreover, they investigated the effects on peo-
ple who had used mobile phones for 10 years or more, 
and this long term use was not associated with higher 
risks of cancer.  
The aim of this study is to provide a descriptive 
trend analysis of population-based brain and CNS 
cancer incidence in Navarre, between 1973 and 2008, 
by gender, age-groups and by two geographical areas. 
The trends of morphological groups are also provided 
during the study period. Finally, projections of cancer 
incidence rates by gender and age-groups are also 
presented until 2014. 
Material and Methods 
This study is based on brain and CNS tumour 
incident cases (C70-C72, International Classification 
of Diseases-10) reported to the Navarre Cancer Reg-
istry. A detailed description of this registry is given 
elsewhere [2, 17, 18]. To guarantee the production of 
reliable data, the Navarre Cancer Registry has quali-
ty-control procedures based on the following quality 
indicators: the percentage of death-certificate-only 
registrations (DCO), the percentage of microscopical-
ly verified cases (MV), the percentage of cases for 
which the age was unknown (UA) and the percentage 
of unspecific morphology (UM). The indicators for the 
period 2003-2008 for this specific site were 1.0% of 
DCO, 53.9% of MV, 0% of UA and 13.7% of UM.  
In this study, the brain and CNS cancer incident 
cases, codes C71-C72 according to the 10th revision of 
International Classification of Diseases (ICD-10) [19], 
diagnosed between 1973 and 2008 were included. The 
population size at risk by 5-year age groups and 
gender was acquired from the Statistical Institute of 
Navarre [20]. Cases coded as C71-C72 (excluding C70) 
were histologically classified following the morpho-
logical groups of brain and CNS cancer defined in 
CI5C Vol IX [21]: gliomas (9380-9384, 9371-9460), em-
bryonal tumours (9470-9474, 9490, 9500-9504, 9508), 
other specific malignant neoplasms, unspecific ma-
lignant neoplasms (8000-8005). Gliomas were also 
classified as astrocytic tumours (9384, 9400-9421, 9424, 
9440-9442), oligodendroglial tumours and mixed 
gliomas (9382, 9450-9451), ependymal tumours (9383, 
9391-9394) and other gliomas (9380-9381, 9423, 9430, 
9444, 9460).  
Due to the geographical differences observed for 
this cancer in Navarre, the area was also considered as 
an explanatory variable of the study. Navarre is a 
small region (644,477 inhabitants is 2011) and a third 
part of the population is concentrated in Pamplona 
(capital city) and hence most number of cases belong 
to the health areas of this city. Then, the observed 
cases were divided in two main areas: Pamplona, an 
urban area with more than 190,000 inhabitants (in the 
year 2012) and non-urban areas that correspond to the 
rest of Navarre.  
Using the registered incident cases and resident 
populations, crude and age-standardized incidence 
annual rates of brain and CNS cancer per 100,000 
person-years were calculated by the direct method 
separately by gender, urban and non-urban areas, 
year of diagnosis, and the following age-groups; 0-14, 
15-44, 45-54, 55-64, 65-74 and, 75+. The world stand-
ard population was used as the reference population 
for age standardization. Assuming that 
age-standardized incidence annual rates are inde-
pendent, averages of annual percentages of change 
(AAPC) were also computed between 1973 and 2008 
for each category (gender, age-group and area). 
Age-standardized rate trends for morphological 
groups are also provided by quinquennia.  
A temporal P-spline model was used to identify 
the age-standardized incidence rate temporal trend 
along the period 1973-2008 and the same model was 
used to forecast brain cancer incidence figures up to 
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2014. More precisely, predictions of incidence rates 
and counts by gender and age-groups were obtained. 
Based on this model incidence rates and new cases 
were obtained up to 2014, where counts were com-
puted multiplying the forecast rates by projections of 
population data [21]. Let us defined the studied pe-
riod as t= 1973…., 2008 the age-standardized rates 
(ASR) in each gender i and time t were modelled us-
ing a gender-specific model defined by  
ASRit=fi(t) 
while the following model was used to model the 
age-specific rate trends (AgSRat)  
AgSRat = f(t) + fa(t) 
In this expression f represents a common tem-
poral trend for all age-groups and  fi  and  fa  are 
smooth functions to capture time trends in each gen-
der and age-group respectively. These functions are 
estimated using the reformulation as linear mixed 
model of the P-splines. All the analyses were carried 
out using R 3.0.0 software [22].  
Results 
A total of 1755 incident cases of brain and other 
CNS cancer were identified among the 19,059,262 
person-years covered by the registry from 1973 to 
2008, which 996 occurred in men and 759 in women. 
In Table 1, the number of cases, person-years, 
age-standardized rates (ASR) and rates ratios are 
provided splitted by period (1973-1990 and 
1991-2008), gender, area (urban and non-urban), and 
age-group. Annual percentage of change of rates and 
the corresponding CI-95% are also provided for the 
entire period. Overall, ASR increased from 6.461 to 
7.033 cases per 100,000 person-years between 
1973-1990 and 1991-2008. By gender, ASRs changed 
from 8.281 to 8.156 in male while in female rate in-
creased from 4.790 to 5.923 between the periods men-
tioned before. By area, higher rates were observed in 
urban than non-urban areas during the entire period 
corresponding to an ASR ratio between urban and 
non-urban areas of 1.236 (CI95% 1.236-1.237) in 
1973-1990 and, 1.126 (CI95% 1.125-1.126) in 1991-2008.  
Table 1. Brain cancer incidence rates and rate ration for the periods 1973-1990 and 1991-2008 
  Period 1973-1990  
  Cases  Population  Rate (CI 95%)  Rate ratio (CI 95%)  
Total   715  9087581  6.461  6.460  6.463     
Gender Women  272  4568870  4.790  4.788  4.792  1  -  -  
 Men  443  4518711  8.281  8.278  8.283  1.729  1.728  1.730  
Area Non-urban  444  5960719  5.994  5.992  5.996  1  -  -  
 Pamplona  271  3126862  7.411  7.409  7.414  1.236 1.236  1.237  
Age-group  0-14  41  1068338 3.813  3.809  3.817  1.170 1,168 1,171 
Men  15-44  66  1989544 3.259  3.256  3.261  1.00  -  -  
 45-54  74  533197  13.523  13.513  13.533  4.149 4,145 4,153 
 55-64  130  448394  29.145  29.129  29.160  8.942 8,933 8,950 
 65-74  83  310884  26.670  26.652  26.689  8.183 8,174 8,191 
 75+  49  168354  27.202  27.178  27.227  8.346 8,336 8,356 
Age-group  0-14  24  1011666  2.279  2.276  2.282  0.887  0.886  0.889  
Women  15-44  50  1899752  2.567  2.564  2.569  1.00  -  -  
 45-54  48  522153  8.829  8.821  8.837  3.439  3.435  3.443  
 55-64  63  483605  13.039 13.029  13.049  5.079  5.073  5.085  
 65-74  57  384512  14.771  14.759  14.783  5.754  5.747  5.761  
 75+  30  267182  11.334  11.321  11.347  4.415  4.408  4.421  
  Period 1991-2008  
  Cases  Population  Rate (CI 95%)  Rate ratio (CI 95%)  
Total   1040  9971681  7.033  7.032  7.035     
Gender  Women 487  5010416  5.923  5.921  5.925  1  -  -  
 Men 553  4961265  8.154  8.151  8.156  1.377  1.376  1.377  
Area Non-urban  639  6571484  6.735  6.733  6.737  1  -  -  
 Pamplona  401  3400197  7.582  7.579  7.585  1.126  1.125  1.126  
Age-group  0-14  33  752050  4.515  4.510  4.520  1.388  1.387  1.390  
Men  15-44  80  2311684  3.251  3.248  3.253  1  -  -  
 45-54  84  642077  12.998  12.990  13.007  3.998  3.994  4.002  
 55-64  100  523748  19.178 19.167  19.191  5.898  5.893  5.904  
 65-74  147  428278  33.799  33.782  33.816  10.395  10.386  10.405  
 75+  109  303428  35.091  35.070  35.112  10.793  10.783  10.803  
Age-group  0-14  16  704775  2.339  2.336  2.343  1.005  1.003  1.007  
Women  15-44  55  2170401 2.327  2.324  2.328  1  -  -  
 45-54  49  618078  7.858  7.851  7.865  3.377  3.373  3.381  
 55-64  94  527424  17.911  17.900  17.932  7.697  7.689  7.705  
 65-74  128  488776  26.258  26.243  26.273  11.284  11.272  11.295  
 75+  145  500962  29.310  29.294  29.325  12.595  12.583  12.608  
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Regarding age-groups, differences were ob-
served between the two periods and gender. In 
1973-1990, males showed higher rates than women 
across the age-groups. Among men, the highest rates 
were observed for those aged between 55-64, 7.106 
cases per 100,000 inhabitants, followed by 65-74 and 
75+ age-groups. Among women, 65-74 age-group 
showed the highest rates, 5.754 cases per 100,000 in-
habitants, followed by 55-64 and 75+ age-groups. In 
the period 1991-2008, women exhibited lower rates 
than men in all the age-groups, being the women 
older than 75 who showed the highest rate 12.595 
cases per 100,000 inhabitants. 
Table 2 shows the average annual percentage of 
change of overall brain cancer incidence rates. These 
results indicate a slightly increase of rates during 1973 
to 2008 by an AAPC of 0.5% (CI95% 0.048%-1.005%). 
By gender, a significant increase of rates was also ob-
served for women by an AAPC of 1.199% (CI95% 
0.187%-2.220%). The AAPC was not significant for 
male. The increase was also significant among 65-74 
and 75+ age-groups, for which the highest AAPC 
were observed, 2.605% (CI95% 1.016%-4.218%) and 
5.885% (CI95% 3.215%-8.625%) respectively.  
Figure 1 shows the brain and CNS cancer inci-
dence rate trends by morphological groups between 
1978 and 2008. A total of 1565 out of 1755 cases 
(89.17%) were classified according to their histology. 
In this figure a clear decrease of unspecific malignant 
neoplasms incidence rate is observed during the pe-
riod, indicating an improvement in the histological 
classification of the cases. Gliomas were the most 
frequent neoplasm. In 2003-2008 the following rates 
per 100,000 inhabitants were observed for each mor-
phological group: gliomas 5.795, unspecific malignant 
neoplasms 0.546, embryonal tumours 0.412 and other 
specific 0.120. In this last period 315 gliomas were 
identified from which 69.8% were astrocytic tumours, 
7.9% were oligodendroglial tumours and mixed gli-
omas, 2.8% ependymal tumours and 19.7% were other 
gliomas.  
Figure 2 shows the age-specific incidence rates 
for the most recent 6-year period available (2003 
through 2008) by gender. Children (0-14 years old) 
and adolescents (15-19 years old) showed the lowest 
rates in both genders with less than four cases per 
100,000 inhabitants. Incidence rates increased slowly 
with age from young adults (35-39years old). After 
age 45 up to 84 years, rates increased sharply in both 
sexes, observing a decline for the oldest age group. 
Figure 3 illustrates trends in age-standardized 
cancer incidence rates from 1973 to 2008 and the pre-
dicted rates for 2014 in men and women (Figure 3A). 
An increasing trend was observed for both sexes, 
more pronounced in female than in male. Figure 3B 
shows the age-specific rate trends along the studied 
period and forecasts for 2014. For those under 64 
years old slightly reduction of age-specific rates are 
observed for the last years of the studied and forecast 
periods, while for the oldest age-groups (65+) a sharp 
increase in rate is shown. For 2014, 78 incident cases of 
brain cancer are predicted.  
Table 2. Average annual percent change (AAPC) in brain cancer 
incidence rates/100,000 person-years by gender, area and 
age-group between 1973 and 2008. 
Annual Percentage of change (CI 95%) between 1973-2008  
  AAPC  95% Confidence Interval  
Total   0.525%  0.048%  1.005%  
Gender  Male  0.140%  -0.491% 0.776%  
 Female  1.199%  0.187% 2.220%  
Area  Urban  0.452%  -0.369% 1.280%  
 Non-urban  0.606%  0.054% 1.161%  
Age-group  0-14  0.671%  -2.136% 3.559%  
 15-44  -0.833%  -2.480% 0.841%  
 45-54  -0.493%  -1.433% 0.456%  
 55-64  -0.533%  -1.401% 0.342%  
 65-74  2.605%  1.016% 4.218%  
 75+  5.885%  3.215% 8.625%  
 
 
Figure 1. Trend of brain cancer and central nervous system incidence rates by morphological groups between 1973 and 2008. 
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Figure 2. Age-specific brain cancer incidence rates in the period 2003-2008. 
 
 
 
 
Figure 3. A. Brain cancer incidence trend estimation and projections by gender. B. Brain cancer incidence trend estimation and projections by age-group. 
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Discussion 
A total of 1755 incident cases of brain cancer 
were identified among 19,059,262 person-years cov-
ered by the cancer registry from 1973 to 2008 which 
involves one of the largest collections in time of brain 
cancer data in Spain. Age-specific rate analysis in the 
last six years pointed out that children and young 
adults had the lowest rates of brain cancer. The results 
also indicated that rates increase with age reaching 
the highest rate for 80-84 age-group, showing a slight 
decline for the oldest age-group (85+ years).  
Incidence rates showed an increase trend along 
the studied period in which men showed higher in-
cidence than women, although differences become 
smaller with time. This is consistent with results of 
other authors [4]. The projections indicate a slight 
increase in rates for 2014 in both sexed. Different hy-
pothesis have been raised in the literature to explain 
gender differences. Some studies indicated that fe-
male sex hormones have a protective effect against 
brain cancer [23]. Others suggested innate differences 
in the susceptibility of X and Y chromosomes to tu-
mourigenic stimuli [24,23], while others pointed out 
that these differences in gender could be explained by 
biological, social or lifestyle factors[25]. Our findings 
also showed a higher brain cancer incidence rates in 
urban areas (city of Pamplona) comparing with rural 
areas. Although many agricultural chemicals and 
pesticides used in rural areas are believed to be brain 
cancer risk factors, we could say that their effects in 
our region are small since the rates in rural areas are 
lower than in urban ones. Mobility of the population, 
mainly elderly people to urban areas, may be a reason 
for these differences between urban and rural inci-
dence rates. Our incidence data only provides the 
residence of the patients at the time of diagnosis. We 
do not consider information about previous resi-
dences. Other studies have considered the air quality, 
air pollution or level of industrial development as 
factors that could explain differences between urban 
and rural areas [23,26], but in our study we do not 
have data to assess these risk factors. Incidence rate 
trends by histological type of brain and CNS cancer 
indicated an increase of gliomas and a clear decrease 
of unspecific malignant neoplasms in the last years. 
These results are consistent with the finding of other 
[23]. 
The improvement on diagnostic techniques al-
lows a more specific diagnosis of this tumour, which 
could have a double effect on the trends. On the one 
hand, improvement of diagnostic rate could lead a 
better morphological classification of these cancers 
reducing the number of unspecific malignant neo-
plasms. On the other hand, these techniques have 
contributed to a better coding of possible brain me-
tastases that formerly could be classified as brain tu-
mours. This could affect the trend in the opposite di-
rection. 
Some studies suggested that an exposure to 
electromagnetic fields or the use of mobile phones 
could be in association with brain cancer develop-
ment. But most of the studies conclude that the asso-
ciation is small or non-significant. It has been also 
indicated that hereditary syndromes, diet and vita-
mins play an important role in adult brain cancers 
[27]. Neither diet, tobacco smoking or alcohol con-
sumption has been found strongly associated with 
increased risk or protective effects for brain cancer in 
adults [28]. The brain cancer incidence rate has in-
creased in recent years in the industrialized countries 
and survival is generally poor compared to many 
other cancers [29]. 
The population-based Navarre Cancer Registry 
was one of the pioneers in Spain starting into opera-
tion in 1970 [18] and it has an important role in cancer 
control, teaching, research and publishing regional 
cancer figures providing useful and reliable incidence 
information of different cancer types. This registry 
contributes to the Cancer Incidence in Five Continents 
(CI5) series edited by the International Agency for 
Research on Cancer (IARC). It means that this cancer 
registry fulfills all quality-criteria and quality-control 
procedures to produce reliable and unbiased data. 
One of the limitations of population-based cancer 
statistics is that data on cancer incidence is available 
to the general public after approximately three or four 
years due to administrative and procedural delays. 
This means that 2014 cancer data will be available in 
2018, and then, there is a gap between the present 
time and the data available. In that context, four-year 
predictions on brain cancer incidence are provided 
based on temporal P-spline models. Accurate forecast 
figures allow public health workers to prioritize pre-
vention activities, to allocate health services, and to 
evaluate the impact of certain interventions up to 
date. Different methods have been used in the litera-
ture in order to forecast cancer incidence mortality 
figures. For example, logarithmic Poisson count data 
joinpoint models, simple log-linear trends, 
age-period-cohort models or autoregressive time se-
ries among others. The P-spline model is appropriate 
to capture smooth temporal trends and to predict 
cancer incidence figures in different groups or areas. 
A spatio-temporal version of the P-spline model has 
been already used in the literature to smoothing and 
forecasting prostate cancer mortality risks in all the 
Spanish provinces within the oncoming years [30].  
To summarize, age-adjusted incidence rates for 
brain cancer showed an increase over the study and 
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forecast period in both sexes. This increase is mainly a 
reflection of the increase of rates in the oldest age 
groups since the rates for younger age groups re-
mained stable or decreased over time. Few causal 
factors are established as a brain cancer risk factor and 
many others have been hypothesized. In this context it 
is necessary to continue promoting healthful lifestyles 
for primary prevention among all the population of 
Navarre.  
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